PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy evaluation in PCI - PROMISE
- Conditions
- coronary angioplastyMedDRA version: 9.1Level: LLTClassification code 10050329Term: Coronary angioplasty
- Registration Number
- EUCTR2006-002726-32-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Indication to elective coronary angioplasty
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Complete block of left branch
Previous myocardial infarct
Arterial Hypertension (> 180/100 mmHg)
Pregnancy or fruitful age
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Study of Dose Finding conducts in an earlier phase to research the optimal physiological effect in terms of increase of the coronary flow and one following phase to research the tolerated maximum dose;Secondary Objective: Study of Dose Finding conducts in an earlier phase to research the optimal physiological effect in terms of increase of the coronary flow and one following phase to research the tolerated maximum dose;Primary end point(s): Measurement of the coronary flow by flow wire
- Secondary Outcome Measures
Name Time Method